Works matching IS 08857490 AND DT 2016 AND VI 31 AND IP 6
Results: 31
What we know: the inflammatory basis of hepatic encephalopathy.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1239, doi. 10.1007/s11011-015-9740-7
- By:
- Publication type:
- Article
Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1315, doi. 10.1007/s11011-015-9716-7
- By:
- Publication type:
- Article
Qualifying and quantifying minimal hepatic encephalopathy.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1217, doi. 10.1007/s11011-015-9726-5
- By:
- Publication type:
- Article
Where are we going? Translational research in hepatic encephalopathy.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1231, doi. 10.1007/s11011-015-9728-3
- By:
- Publication type:
- Article
What is new about diet in hepatic encephalopathy.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1289, doi. 10.1007/s11011-015-9734-5
- By:
- Publication type:
- Article
H and P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1303, doi. 10.1007/s11011-015-9715-8
- By:
- Publication type:
- Article
Clinical science workshop: targeting the gut-liver-brain axis.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1327, doi. 10.1007/s11011-015-9743-4
- By:
- Publication type:
- Article
Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1211, doi. 10.1007/s11011-015-9746-1
- By:
- Publication type:
- Article
The concept of 'the inflamed brain' in acute liver failure: mechanisms and new therapeutic opportunities.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1283, doi. 10.1007/s11011-015-9747-0
- By:
- Publication type:
- Article
Probiotics in management of hepatic encephalopathy.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1295, doi. 10.1007/s11011-016-9826-x
- By:
- Publication type:
- Article
Brain edema: a valid endpoint for measuring hepatic encephalopathy?
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1249, doi. 10.1007/s11011-016-9843-9
- By:
- Publication type:
- Article
Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1269, doi. 10.1007/s11011-016-9858-2
- By:
- Publication type:
- Article
Delayed bradykinin postconditioning modulates intrinsic neuroprotective enzyme expression in the rat CA1 region after cerebral ischemia: a proteomic study.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1391, doi. 10.1007/s11011-016-9859-1
- By:
- Publication type:
- Article
Gene expression profiling of brain cortex microvessels may support brain vasodilation in acute liver failure rat models.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1405, doi. 10.1007/s11011-016-9863-5
- By:
- Publication type:
- Article
Altered expression and localization of synaptophysin in developing cerebellar cortex of neonatal rats due to maternal diabetes mellitus.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1369, doi. 10.1007/s11011-016-9864-4
- By:
- Publication type:
- Article
Evidence of oxidative stress in brain and liver of young rats submitted to experimental galactosemia.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1381, doi. 10.1007/s11011-016-9865-3
- By:
- Publication type:
- Article
Pyridoxine-dependent epilepsy: report on three families with neuropathology.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1435, doi. 10.1007/s11011-016-9869-z
- By:
- Publication type:
- Article
Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1419, doi. 10.1007/s11011-016-9870-6
- By:
- Publication type:
- Article
Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1357, doi. 10.1007/s11011-016-9908-9
- By:
- Publication type:
- Article
Subchronic treatment with acai frozen pulp prevents the brain oxidative damage in rats with acute liver failure.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1427, doi. 10.1007/s11011-016-9873-3
- By:
- Publication type:
- Article
Timosaponin B-II ameliorates scopolamine-induced cognition deficits by attenuating acetylcholinesterase activity and brain oxidative damage in mice.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1455, doi. 10.1007/s11011-016-9877-z
- By:
- Publication type:
- Article
Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1463, doi. 10.1007/s11011-016-9878-y
- By:
- Publication type:
- Article
New technologies - new insights into the pathogenesis of hepatic encephalopathy.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1259, doi. 10.1007/s11011-016-9906-y
- By:
- Publication type:
- Article
Introduction: current state of knowledge of hepatic encephalopathy.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Agomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depression.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1445, doi. 10.1007/s11011-016-9874-2
- By:
- Publication type:
- Article
Current state of knowledge of hepatic encephalopathy (part II): changes in brain white matter tracts integrity are associated with cognitive deficits in minimal hepatic encephalopathy.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1359, doi. 10.1007/s11011-016-9909-8
- By:
- Publication type:
- Article
Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1361, doi. 10.1007/s11011-016-9910-2
- By:
- Publication type:
- Article
Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1365, doi. 10.1007/s11011-016-9912-0
- By:
- Publication type:
- Article
Neuroinflammation in liver disease: sessional talks from ISHEN.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1339, doi. 10.1007/s11011-016-9918-7
- By:
- Publication type:
- Article
Hepatic encephalopathy: present and future.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
- Published in:
- Metabolic Brain Disease, 2016, v. 31, n. 6, p. 1275, doi. 10.1007/s11011-015-9713-x
- By:
- Publication type:
- Article